491
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Prescription Drug Monitoring Programs and Pharmacist Orientation Toward Dispensing Controlled Substances

, &

References

  • American Pharmacists Association. (2014). Pharmacists' role in addressing opioid abuse, addiction, and diversion. Journal of the American Pharmacists Association, 54(1), e5–e15. doi:10.1331/JAPhA.2014.13101 https://doi.org/10.1331/JAPhA.2014.13101.
  • Brandeis University, the Heller School for Social Policy and Management. (n.d.). State Profiles. Retrieved from http://www.pdmpassist.org/content/state-profiles
  • Fass, J. A., & Hardigan, P. C. (2011). Attitudes of Florida pharmacists toward implementing a state prescription drug monitoring program for controlled substances. Journal of Managed Care Pharmacy, 17(6), 430–438. doi:10.18553/jmcp.2011.17.6.430 https://doi.org/10.18553/jmcp.2011.17.6.430.
  • Fleming, M. L., Barner, J. C., Brown, C. M., Shepherd, M. D., Strassels, S. A., & Novak, S. (2014a). Pharmacists' training, perceived roles, and actions associated with dispensing controlled substance prescriptions. Journal of the American Pharmacists Association, 54(3), 241–250. doi:10.1331/JAPhA.2014.13168 https://doi.org/10.1331/JAPhA.2014.13168.
  • Fleming, M. L., Barner, J. C., Brown, C. M., Shepherd, M. D., Strassels, S., & Novak, S. (2014b). Using the theory of planned behavior to examine pharmacists' intention to utilize a prescription drug monitoring program data base. Administrative Pharmacy, 10, 285–296. doi:10.1016/j.sapharm.2013.05.990 https://doi.org/10.1016/j.sapharm.2013.05.009.
  • Gavaza, P., Fleming, M., & Barner, J. C. (2014). Examination of psychosocial predictors of Virginia pharmacists' intention to utilize a prescription drug monitoring program using the theory of planned behavior. Administrative Pharmacy, 10, 448–458. doi:10.1016/j.sapharm.2013.06.011 https://doi.org/10.1016/j.sapharm.2013.06.011.
  • Green, T. C., Mann, M. R., Bowman, S. E., Zaller, N., Soto, X., Gadea, J., … Friedmann, P. D. (2012). How does use of a prescription monitoring program change medical practice? Pain Medicine, 13(10), 1314–1323. doi:10.1111/j.1526-4637.2012.01452 https://doi.org/10.1111/j.1526-4637.2012.01452.x.
  • Green, T. C., Zaller, N., Rich, J., Bowman, S., & Friedmann, P. (2011). Revisiting Paulozzi et al.'s “prescription drug monitoring programs and death rates from drug overdose”. Pain Medicine, 12(6), 982–985. doi:10.1111/j.1526-4637.2011.01136 https://doi.org/10.1111/j.1526-4637.2011.01136.x.
  • Greenbaum, T. (1998). The handbook for focus group research (2nd ed.). Thousand Oaks, CA: Sage Publications.
  • Hagemeier, N. E., Gray, J. A., & Pack, R. P. (2013). Prescription drug abuse: A comparison of prescriber and pharmacist perspectives. Substance Use & Misuse, 48(9), 761–768. doi: 10.3109/10826084.2013.787101 https://doi.org/10.3109/10826084.2013.787101.
  • Hernandez-Meier, J. L., Muscott, R., & Zosel, A. (2017). The use of a statewide prescription drug monitoring program by emergency department physicians. Wisconsin Medical Journal, 116(2), 64–68.
  • Hoppe, J., Howland, M. A., & Nelson, L. (2014). The role of pharmacies and pharmacists in managing controlled substance dispensing. Pain Medicine, 15(12), 1996–1998. doi: 10.1111/pme.12531 https://doi.org/10.1111/pme.12531.
  • Islam, M. M., & McRae, I. S. (2014). An inevitable wave of prescription drug monitoring programs in the context of prescription opioids: Pros, cons and tensions. BMC Pharmacology and Toxicology, 15(46), 1–7. doi:10.1186/2050-6511-15-46
  • Marlowe, K. F., & Geiler, R. (2012). Pharmacist's role in dispensing opioids for acute and chronic pain. Journal of Pharmacy Practice, 25(5), 497–502. doi:10.1177/0897190010379710 https://doi.org/10.1177/0897190010379710.
  • Norwood, C. W., & Wright, E. R. (2016). Integration of prescription drug monitoring programs (PDMP) in pharmacy practice: Improving clinical decision-making and supporting a pharmacist's professional judgment. Research in Social and Administrative Pharmacy, 12, 257–266. doi:10.1016/jspharm.2015.05.008 https://doi.org/10.1016/j.sapharm.2015.05.008.
  • Paulozzi, L. J., Kilbourne, E. M., & Desai, H. A. (2011). Prescription drug monitoring programs and death rates from drug overdose, Pain Medicine, 12(5), 747–754. doi:10.1111/j.1526-4637.2011.01062.x.
  • Ulbrich, T. R., Dula, C. A., Green, C. G., Porter, K., & Bennett, M. S. (2010). Factors influencing community pharmacists' enrollment in a state prescription monitoring program. Journal of the American Pharmacists Association, 50(5), 588–594. doi: 10.1331/JAPhA.2010.09089 https://doi.org/10.1331/JAPhA.2010.09089.
  • Wenthur, C. J., Cross, B. S., Vernon, V. P., Shelly, J. L., Harth, B. N., Lienhoop, A. D., … Murawski, M. M. (2013). Opinions and experiences of Indiana pharmacists and student pharmacists: The need for addiction and substance abuse education in the United States. Research in Social and Administrative Pharmacy, 9(1), 90–100. doi:10.1016/j.sapharm.2012.03.003 https://doi.org/10.1016/j.sapharm.2012.03.003.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.